RankingsPricing
  1. US-listed companies
  2. CAPRICOR THERAPEUTICS, INC.
  3. Financials
  4. FCF margin (%)

CAPRICOR THERAPEUTICS, INC.CAPR

Market cap
$1.2B
P/E ratio
SummaryFinancials
Period EndFCF margin (%) YoY (%)
Dec 31, 2024-184.8+72.95%
Dec 31, 2023-106.9-193.50%
Dec 31, 2022114.3-101.55%
Dec 31, 2021-7,352.3+115.14%
Dec 31, 2020-3,417.4+403.49%
Dec 31, 2019-678.7-19.99%
Dec 31, 2018-848.3+58.59%
Dec 31, 2017-534.9+33.74%
Dec 31, 2016-400+101.60%
Dec 31, 2015-198.4-1329.94%
Dec 31, 201416.1-114.14%
Dec 31, 2012-114-56.18%
Dec 31, 2011-260.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)